The leading cause of cancer-related death in the United States is lung cancer. According to a study published in the Journal of Nuclear Medicine in January, roughly half of Medicare patients with Non-Small Cell Lung Cancer (NSCLC) do not receive the appropriate imaging before radiation treatment. Research has shown that up to 72 percent of..
Category: www.radparts.com - page 6
Breast cancer is the second most common cancer worldwide, affecting approximately 7.8 million women in the past seven years. Current 3D breast cancer treatment focuses on treatment, tissue regeneration, and physical recovery. From prosthetics to drug-loaded implants, challenges persist. With a novel 4D technology, complexity and customization combine to improve breast cancer management. Generally, 3D..
Artificial Intelligence (AI) has been poised to improve the radiological process for some time, yet despite hundreds of conferences, hype, and promises, AI hasn’t made a huge impact yet. Part of the issue with AI’s slow integration for radiologists lies within the application. Algorithms can be applied to specific situations and places, but radiologists need..
Medical equipment professionals often debate whether machines are useful past their “expiration” date. Newer radiation therapy equipment is touted to last seven or eight years, noting that it took roughly seven years to design and program before its release, doubling its age instantaneously. Therefore, the technology, software, and knowledge associated with a 14-year-old device is..
A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don’t know its full potential due to the absence of clinical trials. Niowave has secured a $5 million deal with Fusion..